In vitro and in silico assessment of DNA interaction, topoisomerase I and II inhibition properties of chrysosplenetin

Int J Biol Macromol. 2020 Nov 15:163:1053-1059. doi: 10.1016/j.ijbiomac.2020.07.049. Epub 2020 Jul 13.

Abstract

Chrysosplenetin is a methoxyflavone with reported anti-cancer effect. We tested its cytotoxic effect on the MCF-7 breast cancer cell line, and determined its effect on DNA intercalation and on the activity of topoisomerases I and II. The compound inhibited proliferation MCF-7 with an IC50 value of 0.29 μM. Chrysosplenetin did not initiate plasmid DNA cleavage but, in a concentration-dependent manner, protected plasmid DNA against damage induced by Fenton reagents. Furthermore, it possessed dual Topoisomerase I and II inhibitory properties. Especially, it inhibited topoisomerase II by 83-96% between the range 12.5-100 μM. In the light of these experimental findings, molecular docking studies were performed to understand binding mode, interactions and affinity of chrysosplenetin with DNA, and with topoisomerases I and II. These studies showed that of 4-chromone core and the hydroxyl and methoxy groups important for both intercalation with DNA and topoisomerase I and II inhibition.

Keywords: Chrysosplenetin; DNA; Flavonoid; Flavonol; Topoisomerase.

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Cell Line, Tumor
  • DNA / drug effects*
  • DNA Topoisomerases, Type I / metabolism*
  • DNA Topoisomerases, Type II / metabolism*
  • Drug Screening Assays, Antitumor / methods
  • Flavonoids / pharmacology*
  • Humans
  • Intercalating Agents / pharmacology
  • MCF-7 Cells
  • Molecular Docking Simulation / methods
  • Topoisomerase I Inhibitors / pharmacology*
  • Topoisomerase II Inhibitors / pharmacology*

Substances

  • Antineoplastic Agents
  • Flavonoids
  • Intercalating Agents
  • Topoisomerase I Inhibitors
  • Topoisomerase II Inhibitors
  • DNA
  • chrysosplenetin
  • DNA Topoisomerases, Type I
  • DNA Topoisomerases, Type II